◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0401

Wanjia Group Holdings Limited (0401) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-08-10

Wanjia Group Holdings Limited (0401) operates in the Medical Distribution industry and is headquartered in Kowloon, Hong Kong with about 183 employees. Its market capitalization is roughly HKD 133 million. In the fiscal year ended 2025-03-31, 0401 reported HKD 162M in revenue and (HKD 7M) in net income.

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services.

Interactive charts & full statements →

0401 Revenue & Earnings History — Annual Income Statement

Income statement2025-03-312024-03-312023-03-312022-03-31
Total RevenueHKD 162MHKD 181MHKD 174MHKD 155M
Gross ProfitHKD 50MHKD 55MHKD 57MHKD 54M
Operating Income (EBIT)(HKD 4M)(HKD 15M)HKD 5M(HKD 1M)
Net Income(HKD 7M)(HKD 40M)HKD 2M(HKD 51M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0401 Free Cash Flow History

0401 Balance Sheet History

Balance sheet2025-03-312024-03-312023-03-312022-03-31
Total AssetsHKD 107MHKD 117MHKD 173MHKD 192M
Total LiabilitiesHKD 38MHKD 42MHKD 53MHKD 64M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0401 viewer.

Other Companies in Medical Distribution

← 0400All “0-9” companies0403 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.